Detalhe da pesquisa
1.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 24(1): 229, 2023 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37749551
2.
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 25(1): 152, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38561735
3.
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.
BMJ Open Respir Res
; 11(1)2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38772900